Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysis

Haematologica. 2019 Jul;104(7):e304-e306. doi: 10.3324/haematol.2018.209486. Epub 2019 Jan 10.

Authors

Almuth Hoffmann¹, Sascha Dietrich², Susanne Hain³, Michael Rieger⁴, Ute Hegenbart², Leopold Sellner², Anthony D Ho², Carsten Müller-Tidow², Peter Dreger²

Affiliations

¹ Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg almuth.hoffmann@med.uni-heidelberg.de.
² Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg.
³ Department Medicine III, St. Marienkrankenhaus, Siegen.
⁴ Oncology Practice, Darmstadt, Germany.

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Adult
Algorithms*
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation / mortality*
Humans
Intention to Treat Analysis / methods*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Male
Middle Aged
Patient Selection*
Prognosis
Research Design / statistics & numerical data*
Survival Rate
Transplantation, Homologous